Cesare has more than 20 years’ experience in the drug development field, in both scientific and
commercial roles. He is co-founder and Chief Operating Officer. Prior to that he held senior positions at
AMRI, Aptuit Laurus and ThalesNano. Cesare started his career as research scientist in a
pharmaceutical company (Eisai London) and in academia (institute of Enzymology, Budapest).
Following the death of his first daughter Laura to cancer, Cesare set up the aPODD Foundation, a
London-based charity focused on accelerating paediatric oncology drug development. As aPODD’s
chairman he is actively involved in drug repurposing projects and setting up drug development
collaborations with other childhood cancer charities.
Cesare holds an MSc in Applied Molecular Biology and a PhD in Neurosciences from UCL, University
of London, as well as an MBA from the Central European University, Budapest.